Effects of Telmisartan on Ischemic Cardiovascular Events in High-risk Hypertensive Patients

NCT00863980 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

1500

Enrollment

OTHER

Sponsor class

Stopped Principle investigator resigned in 2013

Conditions

Acute Myocardial Infarction
Angina Pectoris
Myocardial Ischemia
Acute Coronary Syndrome
Hypertension

Interventions

DRUG: Micardis (Telmisartan)
DRUG: Blopress (Candesartan)

Sponsor

Kyoto Prefectural University of Medicine